Stocks and Investing Stocks and Investing
Thu, February 23, 2012
Wed, February 22, 2012

Market Maker Surveillance Report. PFE, SKS, VCSH, CBIS, ACNIQ, EVGI, Highest Net Buy Volume With Lowest Price Friction For Wed


Published on 2012-02-22 18:01:03 - WOPRAI
  Print publication without navigation


February 22, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 3651 companies with "abnormal" market making, 2396 companies with positive Friction Factors and 3469 companies with negative Friction Factors. Here is a list of the top companies with the highest net buy volume on Wednesday and lowest price Friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. PFIZER INC (NYSE:PFE), Saks Inc (NYSE:SKS), VANGUARD S/T CORP BOND ETF (NASDAQ:VCSH), CANNABIS SCIENCE INC (OTCBB:CBIS), American Community Newspapers Inc (OTC:ACNIQ), ECO VENTURES GRP INC (OTCBB:EVGI). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     PFE        $0.120       0.57%        9,979,418       34.92%       6,721,814       23.52%       3,257,604       271,467 
     SKS        $0.030       0.27%        1,975,813       43.65%       995,209         21.98%       980,604         326,868 
     VCSH       $0.030       0.04%        1,224,815       90.59%       127,193         9.41%        1,097,622       365,874 
     CBIS       $0.036       64.29%       35,281,519      57.87%       25,683,273      42.13%       9,598,246       2,666,179
     ACNIQ      $0.027       5,300.00%     3,588,663       66.12%       1,838,972       33.88%       1,749,691       660,261 
     EVGI       $0.010       33.33%       1,464,923       75.55%       474,028         24.45%       990,895         990,895 
Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar gains (Change) and very low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows PFE with a Net Buy Volume of 3,257,604 shares and a Friction Factor of 271,467 shares. That means that it takes 271,467 more shares of buying than selling to move PFE higher by one penny. This means the Market Makers are allowing the stock to move up higher as of Wednesday (lower friction). And with one of the highest Net Buy Volumes, the combination of low friction and high net buy volume is bullish.

PFIZER INC (NYSE:PFE) - Pfizer Inc., a biopharmaceutical company, offers prescription medicines for humans and animals worldwide. The company's Biopharmaceutical segments provides Lipitor for elevated LDL-cholesterol levels in the blood; Enbrel for rheumatoid arthritis, polyarticular juvenile rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, and ankylosing spondylitis; Lyrica for post-herpetic neuralgia, diabetic peripheral neuropathy, fibromyalgia, neuropathic pain, adjunctive treatment of epilepsy, and general anxiety disorder, as well as for use as an adjunctive therapy for adult patients with partial onset seizures; Prevnar/Prevenar for invasive pneumococcal disease; Celebrex for osteoarthritis and rheumatoid arthritis, and acute pain; Viagra for erectile dysfunction; Xalabrands for reducing elevated eye pressure; Effexor XR for depressive, generalized anxiety, social anxiety, and panic disorders; and Norvasc for hypertension. It also offers Zyvox for gram-positive pathogens; Premarin for menopausal symptoms; Sutent for renal cell carcinoma; Geodon/Zeldox for schizophrenia; Detrol/Detrol LA for overactive bladder; Zosyn/Tazocin, an intravenous antibiotic; Genotropin for growth hormone deficiency; Vfend, an antifungal agent; and Protonix for gastroesophageal reflux disease; Chantix/Champix for aid smoking cessation; BeneFIX, ReFacto AF, and Xyntha for lifelong bleeding disorder; Caduet for cardiovascular events; Revatio for pulmonary arterial hypertension; Pristiq for depressive disorder; Aricept for Alzheimers disease; and Spiriva for breathing problems. The companys Diversified segment offers animal health products, such as vaccines, anti-infectives, anti-inflammatories, antiemetics, and parasiticides; consumer healthcare products, such as dietary supplements, pain management, respiratory, and personal care; nutrition products; and gelatin, liquid, softgel, non-animal, and fish gelatin capsules. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Saks Inc (NYSE:SKS) - Saks Incorporated, together with its subsidiaries, operates fashion retail stores in the United States. The companys stores offer a range of luxury fashion apparel, shoes, accessories, jewelry, cosmetics, and gifts. It operates stores under Saks Fifth Avenue (SFA) and Saks Fifth Avenue OFF 5TH (OFF 5th) brand names. SFA stores are principally free-standing stores in shopping destinations or anchor stores in upscale regional malls. OFF 5th stores are primarily located in upscale mixed-use and off-price centers. As of January 30, 2010, Saks operated 53 SFA stores and 55 OFF 5th stores. The company also sells its products through catalogs or Internet at saks.com. It has a credit card strategic alliance with HSBC Bank Nevada, N.A. The company was founded in 1919 and is headquartered in New York, New York.

VANGUARD S/T CORP BOND ETF (NASDAQ:VCSH) - Vanguard Scottsdale Funds - Vanguard Short-Term Corporate Bond Etf

CANNABIS SCIENCE INC (OTCBB:CBIS) - Cannabis Science, Inc. engages in the development, production, and commercialization of phytocannabinoid-based pharmaceutical products. It primarily focuses on developing blood pressure and cancer medications, as well as HIV and bird flu medications. Cannabis Science, Inc. is based in Colorado Springs, Colorado.

American Community Newspapers Inc (OTC:ACNIQ) - American Community Newspapers Inc

ECO VENTURES GRP INC (OTCBB:EVGI) -

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net

Contributing Sources